US HB8289 | 2021-2022 | 117th Congress

Status

Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on July 5 2022 - 25% progression
Action: 2022-07-05 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To require the Secretary of Health and Human Services to promulgate a past due final rule with respect to direct-to-consumer prescription drug advertisements, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Banning Misleading Drug Ads Act of 2022

Sponsors


History

DateChamberAction
2022-07-05HouseReferred to the House Committee on Energy and Commerce.
2022-07-05HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback